Thermo Fisher Scientific has agreed to abandon the proposed acquisition of Gatan from...
- DIY devices are harming diabetic patients as demand for tech grows
- The future of bioprinting: A new frontier in regenerative healthcare
- Entrepreneur is a French word: exploring the French med tech ecosystem
- US medical device tax: should it be gone for good?
- Australian patient data vulnerable to cyber attacks, audit finds
Stryker to invest €200m in RD&I projects in Ireland
US-based medical technology company Stryker has announced plans to invest more than €200m in research, development and innovation (RD&I) projects in Cork, Ireland.
Smith & Nephew to acquire Switzerland’s Atracsys Sarl
UK-based company Smith & Nephew has entered an agreement to buy Swiss optical tracking technology maker Atracsys Sarl for an undisclosed amount.
Thermo Fisher agrees to terminate $925m Gatan acquisition
Thermo Fisher Scientific has agreed to abandon the proposed acquisition of Gatan from software developer Roper Technologies for approximately $925m.
Boston Scientific completes Vertiflex acquisition for $465m
Boston Scientific has closed the acquisition of spine solutions maker Vertiflex for an upfront cash payment of $465m.
DIY devices are harming diabetic patients as demand for tech grows
The number of patients living with diabetes in the US is soaring, as is the demand for high-tech solutions which minimise the impact of the condition on patient’s daily lives. In the absence of any long-term solution, many patients are fashioning their own ‘DIY pancreas’ out of different medical devices – which could be doing untold damage across the country.
The future of bioprinting: A new frontier in regenerative healthcare
While home and office printers don’t seem to have improved in quality since the mid-90s, the world of 3D printing is alive with innovation and potential. The technology has entered the world of medicine through 3D printed devices like prosthetics and surgical instruments, and researchers are now testing out bio-ink as a way of printing vital organs, bones and cartilage.
Entrepreneur is a French word: exploring the French med tech ecosystem
France has a strong, emerging tech start-up landscape, however, the country is especially innovative in med tech due to government and public support for digital solutions to healthcare challenges. Three particularly interesting med tech start-ups operating in France are Doctolib, Revinax and Kap Code.
Medline completes AngioDynamics’ NAMIC portfolio acquisition
Healthcare company Medline has completed the proposed acquisition of NAMIC fluid management portfolio from medical devices firm AngioDynamics for $167.5m.
Read our magazine
Medical Technology is the essential reading material for decision-makers in the medical device industry, bringing you the latest news and analysis in an exciting, interactive format.